Dec. 2 at 7:29 AM
$SGMO ** Give Kids A Chance Act: Passed in U.S. House of Representatives **
“This legislation combines two critical initiatives — the original Give Kids a Chance Act and the Creating Hope Reauthorization Act — to spur drug development for pediatric rare diseases, improve outcomes for patients, and close gaps in pediatric drug research.“
“Priority Review Voucher (PRV) program — originally created under McCaul’s Creating Hope Act — which allows pharmaceutical companies to expedite FDA review of more profitable drugs in return for developing treatments for rare pediatric diseases. Since the bill’s passage in 2011, 63 PRVs have been awarded for at least 39 different rare pediatric diseases.”
“The Mikaela Naylon Give Kids a Chance Act also authorizes the FDA to direct companies to study combinations of cancer drugs and therapies in pediatric trials.”
https://mccaul.house.gov/media-center/press-releases/house-passes-mccauls-landmark-childhood-cancer-legislation
$VKTX $IOVA $TERN
